CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

VOLITIONRX LTD

VNRX
$12M
Micro Cap
NASDAQIn Vitro & In Vivo Diagnostic Substances🇺🇸North AmericaHENDERSON

Drugs in Pipeline

0

Phase 3 Programs

0

Upcoming Catalysts

2

Next Catalyst

Aug 13, 2026

8d

Market Overview

Stock performance and key metrics

VNRX News
Catalyst Timeline

2 upcoming, 0 past

EarningsNext

VNRX Earnings Report

Aug 13, 2026STALE

EPS Est: $-0.70 | FQ end 2026-06

1 more catalyst beyond 14 days

Start a 48-hour free trial to see all upcoming catalysts

Pro

How VNRX's past catalysts played out

Drug Pipeline

No drugs found in this phase.

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Market-Implied Move
Regulatory Approvals

Frequently asked questions

When is VOLITIONRX LTD's next FDA catalyst?

VOLITIONRX LTD's (VNRX) next tracked catalyst is a Earnings expected August 13, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track VNRX biotech catalysts?

Add VNRX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow VOLITIONRX LTD's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply